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Mad2-Independent Inhibition of APCCdc20
by the Mitotic Checkpoint Protein BubR1
has recently begun to unravel. Several molecular com-
ponents of this pathway were initially identified in bud-
ding yeast, including Mad1, Mad2, Mad3, Bub1, Bub2,
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University of Texas Southwestern Medical Center Bub3, and Mps1 (Hoyt et al., 1991; Li and Murray, 1991;
Roberts et al., 1994; Hardwick et al., 1996). Homologsat Dallas
Dallas, Texas 75390 of most of these proteins were then found in other organ-
isms including vertebrates (Chen et al., 1996, 1998; Li
and Benezra, 1996; Taylor and McKeon, 1997; Jin et al.,
1998; Taylor et al., 1998). Interestingly, the vertebrate
Summary homologs of Mad1, Mad2, Bub1, and Bub3 were shown
to localize to kinetochores during mitosis (Chen et al.,
The mitotic checkpoint blocks the activation of the 1996, 1998; Li and Benezra, 1996; Taylor and McKeon,
anaphase-promoting complex (APC) until all sister 1997; Taylor et al., 1998; Martinez-Exposito et al., 1999).
chromatids have achieved bipolar attachment to the In addition, a mammalian protein kinase called BubR1
spindle. A checkpoint complex containing BubR1 and that shares homology with both the yeast Mad3 and
Bub3 has been purified from mitotic human cells. Upon Bub1 proteins was also found at the kinetochores in
checkpoint activation, the BubR1-Bub3 complex inter- mitosis (Chan et al., 1998, 1999; Jablonski et al., 1998;
acts with Cdc20. In the absence of Mad2, BubR1 inhib- Taylor et al., 1998). Subsequent genetic and biochemical
its the activity of APC by blocking the binding of Cdc20 studies showed that, with the exception of Bub2, all of
to APC. Surprisingly, the kinase activity of BubR1 is these molecules are involved in delaying the onset of
not required for the inhibition of APCCdc20. BubR1 also anaphase in the presence of spindle damage, and may
prevents the activation of APCCdc20 in Xenopus egg partially account for the proper timing of chromosome
extracts, and restores the mitotic arrest in Cdc20-over- segregation during normal mitosis (Taylor and McKeon,
expressing cells treated with nocodazole. Because 1997; Fraschini et al., 1999; Li, 1999; Bardin et al., 2000;
BubR1 also interacts with the mitotic motor CENP-E, Bloecher et al., 2000; Gardner and Burke, 2000; Pereira
the ability of BubR1 to inhibit APC may be regulated et al., 2000). Bub1 and BubR1 are protein kinases and
by kinetochore tension or occupancy. both interact with Bub3 (Taylor et al., 1998). Mad1 is a
coiled-coil protein and forms a tight complex with Mad2
throughout the cell cycle (Hardwick and Murray, 1995;
Introduction Chen et al., 1998, 1999). The biochemical function of
Mad2 is relatively well understood. Several lines of evi-
During the cell division cycle, cells first replicate their dence have established that Mad2 binds directly to
DNA and then package the DNA into sister chromatids, Cdc20, an activator of APC, thereby inhibiting the activ-
which are held together by the cohesin protein complex ity of APC (Li et al., 1997; Fang et al., 1998a, 1998b;
(Nasmyth et al., 2000). After all sister chromatids have Hwang et al., 1998; Kim et al., 1998; Dobles et al., 2000).
achieved bipolar attachment to the mitotic spindle, a In contrast, the exact biochemical functions of Bub1,
ubiquitin ligase called the anaphase-promoting complex BubR1, Bub3, and Mad1 are not clear. Because these
or cyclosome (APC) tags the securin protein with poly- proteins localize to kinetochores in mitosis and because
ubiquitin chains (King et al., 1996; Zachariae and Na- several of them interact physically, it has been postu-
smyth, 1999). Degradation of the ubiquitinated securin by lated that these checkpoint proteins may function as
the proteasome in turn activates the proteolytic activity of multiprotein complexes (Chan et al., 1999; Brady and
the separase (Uhlmann et al., 2000). Proteolytic cleavage Hardwick, 2000; Hardwick et al., 2000).
of a cohesin protein by the separase destroys the cohe- Elegant experiments on mammalian cells have re-
sion between the sister chromatids and triggers the on- vealed two extraordinary features of the mitotic check-
set of anaphase (Uhlmann et al., 2000). To ensure the point. First, as a single unattached kinetochore can de-
high-fidelity transmission of the genetic material, the lay the onset of sister chromatid separation, it must
timing of sister chromatid separation is closely moni- generate an inhibitory signal to block the activity of APC
tored by the spindle assembly or mitotic checkpoint (Rieder et al., 1995). Moreover, this signal needs to be
(Straight and Murray, 1997; Burke, 2000). This check-
distributed throughout the cell to account for the inhibi-
point senses the existence of kinetochores not yet occu-
tion of APC that is not associated with the unattached
pied by microtubules (Gorbsky and Ricketts, 1993; Li
kinetochore (Shah and Cleveland, 2000). Although the
and Nicklas, 1995; Nicklas et al., 1995). A single unat-
nature of this diffusive inhibitory signal has not been
tached kinetochore within a cell is sufficient to trigger
established, it is likely to involve the Mad2 protein due
this checkpoint, resulting in the inhibition of APC, the
to its direct role in the inhibition of APCCdc20 and its fast
stabilization of securin, and the delay of the onset of
turnover rate at unattached kinetochores (Howell et al.,anaphase (Nicklas, 1997).
2000). Second, one of the traits of the unattached kineto-The molecular mechanism of the mitotic checkpoint
chores that the checkpoint senses may be the lack of
tension exerted by microtubules (Li and Nicklas, 1995).
This notion is further strengthened by the recent finding1 Correspondence: hongtao.yu@utsouthwestern.edu
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that the kinesin-like motor CENP-E is an essential com- kD BubR1 complex from nocodazole-treated HeLa cells.
ponent of the mitotic checkpoint in mammalian cells Using a combination of conventional and immunoaffinity
and in Xenopus extracts (Abrieu et al., 2000; Yao et al., chromatography, the BubR1 complex was purified to
2000). CENP-E interacts directly with BubR1 in mitosis, homogeneity (Figure 1C). Based on Coomassie staining,
and this interaction may be a part of the force-sensing only two bands, p150 and p40, appeared to be present
mechanism (Chan et al., 1999; Yao et al., 2000). However, at stoichiometric levels (Figure 1D). Identical banding
it is unclear how an imbalance of force can be translated patterns were observed for two different antibodies
into an activity that inhibits APC. against BubR1. The p150 and p40 proteins were sub-
To gain insight into the roles of the checkpoint pro- jected to tryptic digestion followed by liquid chromatog-
teins in transducing the inhibitory kinetochore signal, raphy and tandem mass spectrometry (LC/MS/MS) anal-
we purified a 500 kD BubR1 complex from mitotic HeLa ysis and were identified with high confidence as human
cell lysate using a combination of conventional and BubR1 and human Bub3, respectively. A total of 18 pep-
immunoaffinity chromatography. Mass spectrometric tides spanning 17.7% of the entire length of BubR1 were
analysis revealed that this complex consisted of BubR1 identified, while seven peptides covering 21.6% of the
and Bub3 at a 1:1 molar ratio and that Cdc20 was present Bub3 sequence were detected. Several additional bands
at a substoichiometric level. This was consistent with were present at substoichiometric levels. One of these
the recent finding of Wu et al. that BubR1 associated bands migrating with a molecular mass of 55 kD be-
with Cdc20 in nocodazole-arrested cells (Wu et al., longed to human Cdc20, as mass spectrometric analysis
2000). Purified recombinant BubR1 inhibited the activity identified a peptide corresponding to residues 84–97 of
of APCCdc20 in ubiquitination assays at a much lower human Cdc20.
concentration (Ki  40 nM) as compared to Mad2 (Ki  The presence of Cdc20 in the mitotic BubR1-Cdc20
2 M). BubR1 also blocked the mitotic activation of APC complex was confirmed by immunoblotting (Figure 1E).
in Xenopus extracts. Surprisingly, the kinase activity of In nocodazole-treated cells, Cdc20 was detected in the
BubR1 was not required for its ability to inhibit APC. anti-BubR1 immunoprecipitates, and vice versa. About
Both BubR1 and Mad2 inhibited APC through blocking 4-fold less of Cdc20 was present in the BubR1 immuno-
the binding of Cdc20 to APC. Furthermore, a fragment precipitates from G1/S cells. The increased association
of BubR1 lacking the Bub3 binding domain blocked the between BubR1 and Cdc20 may be due to the fact that
ability of exogenous Cdc20 to prevent mitotic arrest the Cdc20 protein is present at higher levels in mitosis.
in nocodazole-treated HeLa cells. Taken together, our About 4-fold more of Cdc20 appeared to bind to Mad2 in
findings suggest that BubR1 sequesters Cdc20 and in- mitosis, as compared to G1/S. However, Mad2 was not
hibits APCCdc20 in mitosis. Because BubR1 binds to detected in the BubR1 immunoprecipitates (Figure 1E).
CENP-E directly, the affinity of the BubR1-Cdc20 inter-
action at the kinetochores may be regulated by microtu- BubR1 Inhibits APC in Reconstituted Ubiquitination
bule attachment, thus providing a potential link between Assays and in Xenopus Extracts
the molecular sensor of the checkpoint and the inhibition
We next tested whether the association of BubR1 with
of APC.
Cdc20 affected the activity of APCCdc20. APC with only
basal level activity was immunopurified from interphaseResults
Xenopus egg extracts and was incubated with recombi-
nant human Cdc20 protein purified from Sf9 cells, in thePurification of a Mitotic Checkpoint Complex
presence of human Bub1, BubR1, Bub3, or oligomericSeveral mitotic checkpoint proteins, including Bub1,
Mad2 proteins. Purified ubiquitin-activating enzymeBubR1, Bub3, Mad1, Mad2, and Mad3, were reported to
(E1), UbcH10, ubiquitin, ATP, and a fragment of humanform various complexes either in yeast or in mammalian
cyclin B1 were also included in the assay. Addition ofcells (Chan et al., 1999; Brady and Hardwick, 2000; Hard-
Cdc20 to interphase APC greatly enhanced its ligasewick et al., 2000). We therefore examined the fraction-
activity toward cyclin B1, whereas Mad2 inhibited theation profiles of several proteins involved in this pathway
activity of APCCdc20 (Figure 2A). Interestingly, BubR1 alsoon a gel filtration column. Bub1 eluted as part of a 1,000
blocked the activity of APCCdc20. As controls, Bub1 andkD complex in HeLa cells treated with nocodazole, which
Bub3 had no effect on APC activity.depolymerized microtubules and activated the spindle as-
We next compared the potency of BubR1 and oligo-sembly checkpoint (Figure 1A). However, the Bub1 com-
meric Mad2 to inhibit APCCdc20. To our surprise, BubR1plex was also present in cells arrested at the G1/S
inhibited APCCdc20 at a much lower concentration (Ki boundary by thymidine. The fractionation profiles of
40 nM) than Mad2 (Ki  2 M), using either cyclin B1APC2 and Mad2 in mitotic and G1/S lysates did not
(Figure 2B) or human securin (Figure 2C) as substrates.vary, either. In contrast, while BubR1 existed as part of
Based on quantitative immunoblotting, we estimateda 500 kD complex in G1/S cell lysate, a significant portion
that the total concentrations of BubR1, Mad2, Cdc20,of BubR1 was incorporated into a larger complex (1,500
and APC2 in mitotic HeLa cells were around 90 nM, 120kD) when the checkpoint was activated. Interestingly,
nM, 100 nM, and 80 nM, respectively (see Supplementalthe majority of Cdc20 eluted around 250 kD in G1/S
Figure S1 at http://www.developmentalcell.com/cgi/lysate. Upon checkpoint activation, Cdc20 formed two
content/full/1/2/227/DC1). Therefore, BubR1 can inhibitadditional larger complexes, which appeared to coelute
APCCdc20 at the physiological concentration. On the con-with the two forms of BubR1 complexes in the same
trary, the concentration of Mad2 in mitotic HeLa cellslysate (Figures 1A and 1B).
is well below the Ki of 2 M, and is thus not sufficientBecause BubR1 and Cdc20 exhibited a similar frac-
tionation profile in mitosis, we decided to purify the 500 to inhibit APCCdc20 in vivo without intervention from other
BubR1 Inhibits APCCdc20 Independently of Mad2
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Figure 1. Purification of a Mitotic BubR1 Complex
(A) Lysates of HeLa cells arrested at the G1/S boundary by thymidine or in mitosis by nocodazole were fractionated on a Superose 6 gel
filtration column and blotted with various antibodies. The elution volume and the native molecular mass standards are indicated.
(B) The S100 supernatant of the mitotic HeLa cells was fractionated on a Superose 6 gel filtration column. Fractions of 0.25 ml each were
collected, instead of the 1 ml fractions shown in (A). Only the fractions containing the higher molecular weight species of BubR1, Cdc20,
Mad1, and Mad2 were separated by SDS-PAGE and blotted with antibodies against Cdc20, BubR1, Mad2, and Mad1. The two peaks of
Cdc20 coeluted with the two peaks of BubR1. Mad2 fractionated more broadly and peaked differently from BubR1. The fractionation profile
of Mad2 more closely resembled that of Mad1.
(C) Purification scheme of the BubR1 complex. The BubR1-containing fractions were identified by immunoblotting.
(D) The BubR1-containing Superose 6 fractions were combined and immunoprecipitated with two different anti-BubR1 antibodies. The
immunoprecipitates were analyzed by SDS-PAGE followed by Coomassie staining. The bands belonging to BubR1, Bub3, and Cdc20 are
labeled. BubR1 migrates as a doublet. The upper band presumably belongs to the phosphorylated form of BubR1.
(E) Lysates of HeLa cells arrested at the G1/S boundary by thymidine or in mitosis by nocodazole were immunoprecipitated by anti-BubR1,
anti-Cdc20, or anti-Mad2, and blotted with the indicated antibodies.
checkpoint proteins. We then examined whether BubR1 the activities of APC from S, G2, and early mitosis (Fig-
ures 3A and 3B). However, BubR1 did not inhibit theand Mad2 can act synergistically to inhibit APC. BubR1
and Mad2 appeared to inhibit APC in an additive manner activity of APC in late mitosis or G1.
Addition of a nondegradable form of cyclin B, 90-at several concentrations (data not shown). Because the
majority of BubR1 forms a 1:1 complex with Bub3 in cyclin B, is sufficient to drive the interphase Xenopus
egg extracts into mitosis, leading to the activation ofvivo, we coexpressed BubR1 and Bub3 in Sf9 cells and
purified the BubR1-Bub3 complex to homogeneity (Fig- cyclin B/cdc2 and APC. We therefore checked whether
BubR1 inhibited the activity of APC in Xenopus extracts.ure 2D). Binding of Bub3 to BubR1 did not affect the
ability of BubR1 to inhibit APCCdc20, as the BubR1-Bub3 When BubR1 was added to the interphase extracts to-
gether with 90-cyclin B, the degradation of an N-termi-complex inhibited APC at similar concentrations (Fig-
ure 2B). nal fragment of cyclin B1 was effectively blocked (Figure
3C). BubR1 did not block the activation of cyclin B/cdc2BubR1 also inhibited human APC purified from syn-
chronized HeLa cell lysates (Figure 3A). The addition of based on the H1 kinase assay (Figure 3D), indicating
that BubR1 prevented the activation of APC at a laterCdc20 activated APC in S, G2, and early mitosis (Fang
et al., 1998b). When BubR1 protein was added together step. BubR1 also partially inhibited the degradation of
cyclin B1 when added to the mitotic extracts (Figure 3E).with Cdc20, it blocked the ability of Cdc20 to stimulate
Developmental Cell
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Figure 2. BubR1 Inhibits the Activity of APCCdc20
(A) I-APC was isolated from interphase Xenopus egg extracts and incubated with recombinant human Cdc20 protein, in the presence of buffer
(lane 2), BubR1 (lane 3), Bub1 (lane 4), Bub3 (lane 5), and oligomeric Mad2 (lane 6). The ubiquitination activity of APC was assayed with a
Myc-tagged N-terminal fragment of human cyclin B1. The reaction mixtures were separated on SDS-PAGE and blotted with the anti-Myc
antibody. The positions of the cyclin B1 substrate and the cyclin B1-ubiquitin conjugates are labeled.
(B) Dose-response experiments of Mad2, BubR1, and the recombinant BubR1-Bub3 complex. Increasing concentrations of Mad2, BubR1, or
the BubR1-Bub3 complex were added, together with Cdc20, to interphase APC (I-APC) from Xenopus. The concentration ranges of each of
the proteins are indicated.
(C) Same as (B), except that human securin was used as the substrate for APCCdc20 and the oligomeric human Mad2 protein was expressed
and purified from Sf9 cells.
(D) The recombinant BubR1-Bub3 complex and the BubR1 protein produced in Sf9 cells were purified by an Ni2-NTA column followed by a
Superose 6 gel filtration column. The Superose 6 column fractions containing the BubR1-Bub3 complex (gel 1) and BubR1 (gel 2) were
separated on SDS-PAGE followed by Coomassie staining. The bands corresponding to BubR1 and Bub3 are labeled.
However, this effect is less profound than that observed complex is formed, it becomes more resistant to the
actions of BubR1. Mad2 appeared to inhibit APCwith the interphase extracts, consistent with the fact
that the mitotic APC was more resistant to the inhibition through a similar mechanism (Figure 4B). In addition,
Cdc20 associated with the mitotic APC more stronglyof BubR1.
than with the interphase APC because the binding of
Cdc20 to mitotic APC was only blocked at higher con-BubR1 Blocks Binding of Cdc20 to APC
centrations of BubR1 or Mad2. This is presumably dueWe then investigated the mechanism by which BubR1
to the fact that multiple APC subunits become phos-inhibited APC. BubR1 effectively blocked the binding of
phorylated in mitosis, and phosphorylation may in-Cdc20 to the interphase APC (Figure 4A). As shown
crease the affinity of APC toward Cdc20 (Peters et al.,previously, Cdc20 further stimulated the activity of the
1996; Fang et al., 1998b; Kotani et al., 1999; Kramer etmitotic APC. BubR1 inhibited the stimulatory effect of
al., 2000).Cdc20 on mitotic APC by preventing Cdc20 binding.
However, it did not reduce the activity of the mitotic
APC down to the basal level of the interphase APC. The Kinase Activity of BubR1 Is Not Essential
for Inhibition of APCThis is consistent with our findings that BubR1 did not
completely inhibit the degradation of cyclin B in mitotic BubR1 achieved maximal inhibition of APCCdc20 at
roughly a 1:1 molar ratio with Cdc20. Furthermore,extracts and that BubR1 failed to block the activity of
APC isolated from mitotic HeLa cell lysates. Therefore, BubR1 inhibited APCCdc20 in the presence of AMP-PNP
(data not shown). Although AMP-PNP can effectivelyBubR1 inhibits the activity of APC by blocking the forma-
tion of the active APCCdc20 complex. Once the APCCdc20 support the ubiquitination reaction, it cannot be used
BubR1 Inhibits APCCdc20 Independently of Mad2
231
Figure 3. BubR1 Inhibits the Activity of Human APCCdc20 and Blocks the Activation of APC in Xenopus Egg Extracts
(A) HeLa cells were synchronized at the G1/S boundary by a double-thymidine block, released into fresh medium, and harvested at the
indicated time points after the removal of thymidine (2, 6, 8, 10, 12, and 14 hr). APC was isolated from the synchronized HeLa cell lysates,
incubated with Cdc20 in the presence () and absence () of BubR1, and assayed for ubiquitination activity.
(B) The same cell lysates used in (A) were blotted with anti-cyclin B1 antibody. The cell cycle status of these lysates is labeled above.
(C) The 90-cyclin B protein was added to the interphase Xenopus egg extract (I-XT) in the presence or absence of BubR1. After 90 min of
the addition of 90-cyclin B, the Myc-tagged N-terminal fragment (1–102) of human cyclin B1 was added. Samples were taken at the indicated
time points and blotted with anti-Myc antibody.
(D) The same extracts, prior to the addition of the N-terminal cyclin B fragment, were assayed for histone H1 kinase activity.
(E) Interphase Xenopus egg extract was incubated with 90-cyclin B for 90 min. The resulting mitotic extract (M-XT) was assayed for its ability
to degrade the N-terminal cyclin B1 fragment in the absence or presence of BubR1.
by kinases to phosphorylate substrates. These results of BubR1, K795A, which was likely to disrupt its ability
to bind ATP. As expected, the K795A mutation abolishedsuggested that BubR1 did not function catalytically. To
confirm this, we constructed a kinase-inactive mutant the ability of BubR1 to autophosphorylate, suggesting
Figure 4. BubR1 and Mad2 Block the Binding of Cdc20 to APC
(A) APC was isolated from either interphase (I-APC) or mitotic (M-APC) Xenopus egg extracts. The APC beads were incubated with Cdc20 in
the presence of increasing concentrations of BubR1. After washing, these beads were assayed for ubiquitination activity and blotted with
anti-Cdc20 antibody.
(B) APC was isolated from either interphase (I-APC) or mitotic (M-APC) Xenopus egg extracts. The APC beads were incubated with Cdc20 in
the presence of increasing concentrations of oligomeric Mad2. After washing, these beads were assayed for ubiquitination activity and blotted
with anti-Cdc20 antibody.
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Figure 5. The Kinase Activity of BubR1 Is Not
Required for Inhibition of APCCdc20
(A) Schematic drawing of the regions within
BubR1 that are essential for inhibiting APC,
binding to Cdc20, or binding to Bub3.
(B) Purified BubR1 and its mutant proteins
were analyzed by SDS-PAGE followed by
Coomassie blue staining. The fast-migrating
species in the BubR1 and BubR1-K795A
lanes belong to degradation products of
these two proteins.
(C) Interphase APC was incubated with
Cdc20 in the presence of an equal molar
amount (100 nM) of various BubR1 mutant
proteins and assayed for ubiquitination activ-
ity. The control lane (lane 11) did not con-
tain APC.
that BubR1-K795A might not possess kinase activity binding assay between Mad2 and Cdc20 was also re-
peated. We had previously shown that Mad2 interacted(data not shown). To identify the regions within BubR1
responsible for the inhibition of APC, a series of BubR1 with a small fragment within the N-terminal region of
Cdc20 (Luo et al., 2000). Digestion of in vitro-translatedtruncation mutants were prepared (Figures 5A and 5B).
The kinase-inactive BubR1-K795A mutant inhibited 35S-labeled Cdc20 with chymotrypsin resulted in two
well-defined fragments of roughly 40 kD and 16 kD inAPCCdc20 with equal efficiency as the wild-type BubR1
protein (Figure 5C). Therefore, the kinase activity of size (Figure 6A). Immunoblotting revealed that the 16
kD fragment contained the N terminus of Cdc20, whileBubR1 was dispensable for the inhibition of APCCdc20.
Furthermore, two overlapping fragments of BubR1, the 40 kDa fragment corresponded to its C-terminal
BubR1b (residues 526–1050) and BubR1f (residues WD40 domain (data not shown). Therefore, Cdc20 in-
1–700), inhibited APC at similar concentrations as the deed behaved like a two-domain protein. Two truncation
intact BubR1 (Figure 5C). This suggested that the region mutants of Cdc20 corresponding to the N- and C-termi-
spanning residues 526–700 might be critical for the in- nal domains were then constructed (Figure 6B). The
hibitory activity of BubR1. Alternatively, BubR1 might wild-type oligomeric Mad2 interacted strongly with the
contain multiple Cdc20 binding sites. The latter possibil- N-terminal domain of Cdc20, as did a monomeric form of
ity was more consistent with the fact that the BubR1d a Mad2 mutant (with the N-terminal ten residues deleted,
fragment containing residues 351–700 had no inhibitory N10-Mad2). As a control, the Mad2 mutant with its
activity toward APC (Figure 5C). Therefore, the APC- C-terminal ten residues deleted (C10-Mad2) did not
inhibitory region of BubR1 cannot be localized to a single bind to Cdc20. As expected, none of the Mad2 proteins
small domain. However, a fragment of BubR1 lacking associated with the C-terminal WD40 domain of Cdc20.
the entire kinase domain (BubR1f) was sufficient to in- Unexpectedly, both the monomeric and oligomeric
hibit APC, further supporting the notion that the kinase forms of Mad2 interacted only weakly with the intact
activity of BubR1 was not required for APC inhibition. Cdc20. The weak interaction between Mad2 and the
intact Cdc20 was not due to the inability to form the
Mad2-Cdc20 complex posttranslationally, because onlyBinding between BubR1 and Cdc20 Requires
minor portions (about 20%) of Mad2 and Cdc20 werethe Intact Cdc20
able to form a complex even when both proteins wereWe next examined the binding between Cdc20 and the
coexpressed in Sf9 cells (data not shown). Similar resultsBubR1 fragments. To qualitatively compare the affinities
of the BubR1-Cdc20 and Mad2-Cdc20 interactions, the were also obtained in a yeast two-hybrid assay (data
BubR1 Inhibits APCCdc20 Independently of Mad2
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Figure 6. Binding of Cdc20 to BubR1 and Mad2
(A) 35S-labeled Cdc20 protein was digested with 10 g/ml chymotrypsin (Roche) for 10 min at room temperature and separated on SDS-PAGE
followed by autoradiography. The bands belonging to the two domains of Cdc20 are labeled.
(B) Schematic drawing of the boundaries of the Cdc20 constructs corresponding to the N-terminal and C-terminal domains of Cdc20.
(C) The wild-type Mad2 oligomer, the monomeric Mad2 protein with its C-terminal ten residues deleted (C10-Mad2), and the monomeric
Mad2 protein with its N-terminal ten residues deleted (N10-Mad2) were bound to Ni2-NTA beads and incubated with the 35S-labeled Cdc20,
the N-terminal domain of Cdc20 (Cdc20N), or the C-terminal domain of Cdc20 (Cdc20C). After washing, the proteins retained on the beads
were analyzed by SDS-PAGE followed by autoradiography.
(D) Various BubR1 mutant proteins were bound to Ni2-NTA beads and incubated with the 35S-labeled Cdc20, the N-terminal domain of Cdc20
(Cdc20N), the C-terminal domain of Cdc20 (Cdc20C), or Bub3. Empty Ni2-NTA beads were used as the control. After washing, the proteins
retained on the beads were analyzed by SDS-PAGE followed by autoradiography.
(E) Various BubR1 mutant proteins were bound to Ni2-NTA beads and incubated with the 35S-labeled Bub3 or Cdc20 in the absence or
presence of nonlabeled human Cdc20 protein purified from Sf9 cells. After washing, the proteins retained on the beads were analyzed by
SDS-PAGE followed by autoradiography.
not shown). Therefore, Mad2 cannot form a complex Cdc20 and the ability of BubR1 to inhibit APCCdc20. BubR1
might inhibit APCCdc20 only when an extensive interactionefficiently with the intact Cdc20 in the absence of other
checkpoint proteins. between BubR1 and Cdc20 is established, which in-
volves multiple contact sites between large segmentsIn contrast, BubR1 did not bind to either the N- or
C-terminal domains of Cdc20. However, it interacted of the BubR1 and Cdc20 proteins.
We also mapped the region of BubR1 that was respon-strongly with the intact Cdc20 (Figure 6D). The two
BubR1 fragments that were sufficient to inhibit APC, sible for binding to Bub3. As shown in Figure 6D, BubR1a,
BubR1d, and BubR1f interacted with Bub3. Therefore,BubR1b and BubR1f, also associated with Cdc20. Inter-
estingly, although the BubR1d fragment did not inhibit the Bub3 binding region of BubR1 is likely to reside in
residues 351–525. This is consistent with earlier findingsAPC, it appeared to be sufficient for binding to Cdc20.
There are several plausible explanations for this finding. that residues 392–433 of BubR1 are required for binding
to Bub3 (Taylor et al., 1998). We tested whether theThe BubR1d fragment might not interact with Cdc20 as
strongly as the intact BubR1 or the other functional interactions of Bub3 and Cdc20 with BubR1 were mutu-
ally exclusive. Though nonlabeled Cdc20 protein pro-BubR1 fragments. The difference in affinity cannot be
distinguished by our qualitative binding assays. It is duced in Sf9 cells efficiently displaced the binding of
35S-labeled Cdc20 to BubR1, it did not block the bindingalso possible that the BubR1d fragment is not properly
folded, which generates a nonnative molecular surface of 35S-labeled Bub3 to BubR1 (Figure 6E). Therefore,
both Bub3 and Cdc20 can simultaneously bind to BubR1that interacts with Cdc20 nonspecifically. Finally, there
might be a distinction between the binding of BubR1 to to form a ternary complex. This is consistent with our
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Figure 7. BubR1 Inhibits APCCdc20 in HeLa Cells
(A) HeLa cells were transfected with either pCS2-GFP alone or pCS2-GFP together with pCS2-Cdc20, treated with nocodazole, and stained
with Hoechst 33342. GFP is shown in green and DNA staining is shown in blue.
(B) HeLa cells were transfected with the indicated plasmids together with pCS2-GFP and treated with nocodazole. The transfected cells are
shown in green.
(C) The mitotic index of cells transfected with various plasmids. The results were obtained by counting cells in three separate fields with at
least 100 cells each and averaged.
(D) A model for the spindle assembly checkpoint. See Discussion for details.
finding that the BubR1-Bub3 complex inhibited APCCdc20 inhibit APC did not restore the mitotic arrest (Figures
7B and 7C). Unexpectedly, overexpression of BubR1das efficiently as BubR1 alone.
alone reduced the mitotic index of transfected cells
upon nocodazole treatment. Because BubR1d retainedBubR1 Counteracts the Effect of Cdc20
Overexpression in Living Cells the ability to bind Bub3, this fragment might interfere
with the function of Bub3 in a dominant-negative fash-In budding yeast, cells overexpressing Cdc20 do not
arrest in mitosis in response to spindle damage, presum- ion. Consistent with the hypothesis, cotransfection of
Bub3 with BubR1d restored the mitotic arrest in nocoda-ably because elevated levels of Cdc20 activate APC and
allow cells to bypass the mitotic checkpoint (Hwang et zole-treated cells (Figures 7B and 7C). Taken together,
our data suggest that BubR1 can inhibit APCCdc20 in livingal., 1998; Schott and Hoyt, 1998). Overexpression of
Cdc20 in mammalian cells caused a similar phenotype cells and that Bub3 is important for checkpoint sig-
naling.(Figure 7A). HeLa cells were transfected with plasmids
encoding Cdc20 and GFP, treated with nocodazole at
300 nM for 24 hr, and stained with Hoechst 33342. Upon Discussion
nocodazole treatment, about 80% of cells transfected
with GFP alone arrested in mitosis, as judged by cell Tremendous progress has been made in the identifica-
tion of the molecular components of the spindle assem-shape and DNA morphology (Figure 7). Cotransfection
of GFP and Cdc20 greatly reduced the mitotic index bly checkpoint from various organisms. However, how
these proteins interact with each other to generate the(18%) of transfected cells in the presence of nocodazole.
We next checked whether BubR1 could restore the mi- checkpoint signal in response to unattached kineto-
chores remains a mystery (Shah and Cleveland, 2000).totic arrest of the Cdc20-overexpressing cells. When
cells were cotransfected with Cdc20 and the BubR1b The results reported here establish that the checkpoint
kinase BubR1 can directly inhibit APCCdc20 independentlyfragment, about 80% of cells arrested in mitosis in the
presence of nocodazole (Figure 7). As a control, cotrans- of Mad2. Moreover, BubR1 is a much more potent inhibi-
tor of APCCdc20 as compared to Mad2 in vitro. Therefore,fection of Cdc20 and the BubR1d fragment that cannot
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our findings suggest that the BubR1-Bub3 complex may further supported by the fact that, despite the existence
of homology region I in human Bub1, no significant inter-act, in a pathway parallel to Mad2, to inhibit APCCdc20
(Figure 7D). action was observed between Bub1 and Cdc20 in HeLa
cells (Figure 1A and data not shown).
BubR1 as the Mammalian Homolog of Yeast Mad3
On the basis of sequence analysis alone, it is difficult Sequestration of Cdc20 by BubR1
to determine whether BubR1 is the ortholog of yeast Based on the genetic and biochemical studies in yeast
Mad3 (Murray and Marks, 2001). The homology between and metazoans, it has become increasingly clear that
BubR1 and the yeast Mad3 protein is restricted to the the mitotic checkpoint proteins form a complicated sig-
N-terminal 200 residues; this region also shares se- naling network, instead of a linear pathway (Burke,
quence similarity to the yeast Bub1 protein. In addition, 2000). In several organisms, numerous complexes of
the yeast Mad3 protein lacks a C-terminal kinase do- checkpoint proteins, including Mad1-Mad2, Bub1-
main. Despite the ambiguity in sequence alignment and Bub3, and Mad3/BubR1-Bub3, are detected throughout
the difference in domain structure between BubR1 and the cell cycle. Other checkpoint complexes, such as
Mad3, our biochemical results support the notion that BubR1-Bub3-Cdc20 and Mad2-Cdc20, seem to be en-
BubR1 is the functional homolog of yeast Mad3. In yeast, riched in mitotic cells, possibly due to the higher concen-
Mad3 interacts with Cdc20 physically, and the Mad3- trations of Cdc20 in mitosis. Upon checkpoint activation,
Cdc20 interaction is critical for checkpoint signaling. some of these complexes may interact transiently to
This is consistent with the data of Wu et al. and our produce even larger macromolecular assemblies, and
finding that BubR1 binds directly to Cdc20 (Wu et al., such larger complexes may also be important for the
2000). In addition, BubR1 can inhibit the ability of ectopi- inhibition of APC. Therefore, it is critical to dissect the
cally expressed Cdc20 to prevent mitotic arrest in the individual contributions of these interactions to check-
presence of spindle damage. More importantly, the ki- point signaling.
nase activity of BubR1 is dispensable for the inhibition Both Mad2 and BubR1 can interact with Cdc20 and
of APCCdc20 in vitro. Though BubR1 contains a Bub1- inhibit APCCdc20 in vitro. What are the physiological func-
like kinase domain at its C terminus, there is so far no tions of these interactions? One simple model is that
evidence to indicate that the kinase acitivity of BubR1 Mad2 and BubR1 act in parallel pathways and sequester
is required for its function in the checkpoint pathway. different pools of Cdc20 to block the activation of APC.
Therefore, in terms of mechanism of action, BubR1 is Both proteins are required to effectively inhibit APCCdc20
more closely related to the yeast Mad3 protein than to in living cells. Consistent with this sequestration model,
the yeast Bub1 protein. both Mad2 and BubR1 are present at relatively high
In yeast, the N-terminal region (homology region I) of concentrations in cells. The concentrations of Mad2 and
Mad3 is required for its interaction with Cdc20 (Hardwick BubR1 in HeLa cells are estimated to be 120 nM and
et al., 2000). Our data suggest that BubR1 might contain 90 nM, respectively, which are comparable to the con-
multiple Cdc20 binding regions and that binding of centration of Cdc20 (100 nM) in mitotic cells (see Supple-
BubR1 to Cdc20 might involve an extensive interface, mental Figure S1). Furthermore, Mad2 and BubR1 ap-
involving the entire Cdc20 protein and large segments pear to inhibit APCCdc20 in an additive fashion in vitro
of BubR1. At present, we do not fully understand the (data not shown). Alternatively, it is possible that, in
reason for this discrepancy. However, neither the assays addition to sequestering Cdc20, binding of BubR1 and
of Hardwick et al. (yeast two-hybrid and immunoprecipi- Cdc20 helps to recruit Cdc20 to kinetochores at pro-
tation) nor our in vitro binding assays are quantitative metaphase, facilitating the formation of other inhibitory
(Hardwick et al., 2000). Therefore, it is entirely possible checkpoint complexes containing Mad2 and Cdc20. Yet
that some of the fragments of Mad3 and BubR1 might another possibility is that BubR1 and Mad2 might re-
have lost certain Cdc20 binding elements and bind to spond to distinct forms of spindle damage during mito-
Cdc20 with weaker affinity than their full-length counter- sis. As recently suggested by Skoufias et al., Mad2 might
parts. In fact, based on a yeast two-hybrid assay, the sense the attachment of microtubules to kinetochores,
homology region I alone of Mad3 interacted with Cdc20 whereas BubR1 might respond to the lack of tension at
significantly more weakly than the full-length Mad3 (Hard- the kinetochores (Skoufias et al., 2001). The hypothesis
wick et al., 2000). Consistent with our data, truncation that BubR1 is involved in tension sensing is consistent
of a small C-terminal region (residues 410–515) of Mad3 with the fact that BubR1 interacts with the mitotic motor
significantly weakened the interactions between Mad3 CENP-E during mitosis (Abrieu et al., 2000; Yao et al.,
and Cdc20 (Hardwick et al., 2000). Alternatively, this 2000). It is conceivable that binding of the BubR1-Bub3
discrepancy might be a consequence of the rather diver- complex to Cdc20 might be regulated by CENP-E in
gent amino acid sequences of the yeast and human response to tension at the kinetochores.
proteins. Although the C-terminal WD40 domains of the
yeast and human Cdc20 proteins are conserved, there Experimental Procedures
is little sequence homology between the N-terminal do-
mains of these two proteins. Because both the N- and Antibody Production, Immunoprecipitation,
and ImmunoblottingC-terminal domains of human Cdc20 are required for
To generate antibodies against Bub1 and BubR1, several fragments,binding to BubR1, it is possible that BubR1 may use
including Bub1N (residues 1–200), BubR1N1 (residues 1–200), andmultiple binding determinants to interact with human
BubR1N2 (residues 201–400), were expressed as GST fusion pro-
Cdc20. Due to sequence differences in the Cdc20 pro- teins in bacteria and purified. The proteins were used to immunize
teins, some of these binding elements may not be strictly rabbits at Zymed Laboratories. The antisera were purified using
the appropriate antigens. The production of anti-APC2, anti-APC3conserved between yeast and human. This notion is
Developmental Cell
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(Cdc27), and anti-Mad2 polyclonal antibodies was reported pre- ubiquitination assay was performed in a volume of 5 l. The reaction
mixture contained an energy-regenerating system, 150M of bovineviously (Fang et al., 1998a, 1998b). A goat polyclonal anti-Cdc20
antibody was purchased from Santa Cruz Biotechnology. The anti- ubiquitin, 5 M of the Myc-tagged N-terminal fragment of human
cyclin B1, 5 M of human E1, 2 M of UbcH10, and 2 l of the APCMyc (9E10) monoclonal antibody was purchased from Roche. For
immunoblotting, the antibodies were used at a 1:1000 dilution of beads. The reactions were incubated at room temperature for 1 hr,
quenched with SDS sample buffer, and analyzed by SDS-PAGEcrude serum or at 1g/ml of affinity-purified IgG. For immunoprecip-
itation, antibodies were coupled to Affi-Prep Protein A beads (Bio- followed by immunoblotting with anti-Myc.
To isolate human APC, HeLa cells were grown in the presence ofRad) at a concentration of 1 mg/ml.
2 mM thymidine (Sigma) for 18 hr to arrest the cell cycle at the G1/S
boundary, washed with PBS, and grown in fresh medium withoutPurification of the BubR1-Bub3 Complex
thymidine for 8 hr. Cells were then incubated with 2 mM thymidineHeLa cells were grown in Dulbecco’s modified Eagle’s medium
for another 18 hr, transferred into fresh medium, and harvested at(DMEM; Gibco) supplemented with 10% fetal bovine serum. For the
various time points. The cells were lysed with NP-40 lysis buffer.purification of the BubR1-Bub3 complex, a total of 40 plates (150
The cell lysates were then incubated with the anti-APC3 antibodymm) of HeLa cells were grown to confluency, treated with 300 nM
beads for 2 hr at 4C. The beads were then washed, incubated withnocodazole for 18 hr, and harvested. The cells were lysed with the
Cdc20 and other proteins, and assayed for ubiquitination activityNP-40 lysis buffer (50 mM Tris-HCl [pH 7.7], 150 mM NaCl, 0.5%
as described above.NP-40, 1 mM DTT, 10% glycerol, 0.5 M okadaic acid, and 10 g/
ml each of leupeptin, pepstatin, and chymostatin). The lysate was
Binding Assaycentrifuged at 40,000 rpm for 1 hr. The supernatant was fractionated
The full-length Cdc20 and the N- and C-terminal fragments of Cdc20on a 50 ml resource Q column (Pharmacia). Ammonium sulfate was
were translated in reticulocyte lysate in the presence of [35S]methio-added to the BubR1-containing fractions to 30% saturation and the
nine. Purified His6-tagged Mad2 proteins (wild-type, N10, andresulting precipitates were dissolved and fractionated on a 26 ml
C10) were bound to Ni2-NTA beads, incubated with the 35S-labeledSuperose 6 column (Pharmacia). The BubR1-containing fractions
Cdc20 protein, and washed three times with TBS containing 0.05%were combined and subjected to immunoprecipitation by two differ-
Tween. The proteins retained on beads were analyzed by SDS-ent anti-BubR1 antibodies. After extensive washing, the antibody
PAGE followed by autoradiography. Binding of BubR1 to Cdc20 andbeads were eluted with 100 mM glycine (pH 2.5), concentrated, and
Bub3 was assayed similarly.analyzed by SDS-PAGE, followed by staining with Coomassie blue
(Bio-Rad). The protein bands were excised and subjected to LC/
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